This inventor holds 6 USPTO granted patents. Top assignees: Allergan, Inc., Allergan Sales, Inc., Advanced Medical Optics, Inc.. Active years: 2000-2010.
Company Filing History:



Years Active: 2000-2010
Title: Innovations by Rodney J Terwilliger
Introduction
Rodney J Terwilliger is a notable inventor based in Buena Park, CA (US). He has made significant contributions to the field of medication compliance through his innovative approaches. With a total of 6 patents, Terwilliger has developed methods that enhance patient adherence to medication regimens.
Latest Patents
One of his latest patents is titled "Memantine titration/compliance dosage methods." This invention features a titration package designed to facilitate compliance with a regimen of changing dosages of medication over time. The package includes a backing with an array of receivers organized in columns and rows. Each set of Memantine tablets has a common dose of medication, differing from other sets. The design allows for easy identification of dosages through adjacent indicia that display common days and successive weeks.
Another significant patent is the "Titration/compliance pack with increasing doses." Similar to his previous invention, this titration package also includes a backing with an array of receivers. It provides a structured method for patients to follow their medication dosages, ensuring they can easily manage their treatment over time.
Career Highlights
Throughout his career, Terwilliger has worked with prominent companies such as Allergan, Inc. and Allergan Sales, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for medication management.
Collaborations
Some of his notable coworkers include John W Vanden Dries and John Jacob Vander Zanden. Their collaboration has likely played a role in the development of Terwilliger's innovative patents.
Conclusion
Rodney J Terwilliger's contributions to medication compliance through his patents demonstrate his commitment to improving patient care. His innovative approaches have the potential to significantly enhance the way patients manage their medication regimens.